Abbott Laboratories has reopened a Michigan plant whose closures over the past few months fueled a national shortage of baby formula.
The company began operations on July 1 at its Sturgis, Mich., infant formula plant, which was closed last month due to heavy rains, a company spokesman told Reuters on Saturday.
The company saw its Sturgis facility shut down by the Food and Drug Administration in February after two babies died from a rare bacteria that may have originated in the plant.
At the time, it also recalled infant products, including Similac, in response to reports of bacterial infections in babies who consumed products made at the facility.
Before the recall, Abbott controlled 40% of the infant formula market.
Abbott briefly reopened the plant on June 4, but had to close it less than two weeks later after it was hit by thunderstorms and heavy rains that swept through Sturgis, causing power outages and widespread flooding.
Abbott Laboratories initially closed in February after two babies died from a rare bacteria that may have come from the plant. Brandon Watson/Sturgis Journal/AP
Abbott has resumed production of specialty infant formula EleCare.
With pole cables.
Add Comment